| Apr 27, 12 | Man jumps on broker upgrades and continuing bid talk, as FTSE finishes week on positive note | | No data |
| Apr 27, 12 | AstraZeneca boss David Brennan quits under pressure from investors | | No data |
| Apr 26, 12 | AstraZeneca: What the analysts say | | No data |
| Apr 26, 12 | David Brennan's successor faces unenviable task at AstraZeneca | | No data |
| Apr 23, 12 | AstraZeneca buys gout drug maker Ardea | | No data |
| Apr 3, 12 | Markets retreat after Monday's surge but Cairn climbs on north sea deal | | No data |
| Apr 3, 12 | AstraZeneca investors encouraged by partnership with US group Amgen, but FTSE slips back | | No data |
| Mar 30, 12 | FTSE 100 ends quarter on upbeat note but Shire and Vodafone suffer | | No data |
| Mar 30, 12 | AstraZeneca climbs after US Seroquel patent victory, as mining groups lift FTSE 100 higher | | No data |
| Mar 28, 12 | Icap drops after trading update while FTSE 100 struggles to regain ground | | No data |
| Mar 26, 12 | Boardroom pay packages close to £10m are on the rise | | No data |
| Mar 22, 12 | BAE Systems dips on talk of interest in US group Esterline, as FTSE falters on growth worries | | No data |
| Mar 22, 12 | AstraZeneca tipped to buy US group Forest, as it loses Seroquel patent case | | No data |
| Mar 6, 12 | Inmarsat falls despite profit rise, on worries about US partner LightSquared | | No data |
| Mar 5, 12 | Game Group slips again on concerns about its future, while FTSE falls on Greek and China woes | | No data |
| Mar 1, 12 | Thomas Cook drops by a fifth on downgrade, but FTSE 100 moves higher as EU meets | | No data |
| Mar 1, 12 | AstraZeneca appoints new chairman | | No data |
| Feb 27, 12 | Nomura suggests a pick-up in merger activity and tips 35 possible targets | | No data |
| Feb 15, 12 | FTSE slightly down on Greek woes | | No data |
| Feb 15, 12 | Stock markets rise on Greece optimism | | No data |
| Feb 3, 12 | FTSE 100 records fourth successive daily rise as US jobs data beats forecasts | | No data |
| Feb 2, 12 | AstraZeneca job cuts expose dilemma facing the pharmaceutical industry | | No data |
| Feb 2, 12 | AstraZeneca to cut 7,300 jobs | | No data |
| Feb 2, 12 | Unilever loses 3% after City dislikes Marmite maker's figures | | No data |
| Jan 30, 12 | FTSE closes lower; financial and resource stocks down | | No data |
| Jan 30, 12 | Market seeks shelter in defensive stocks ahead of EU summit | | No data |
| Jan 19, 12 | BP could have to pay $25bn to settle Gulf oil spill claims, says bank | | No data |
| Jan 10, 12 | Marks & Spencer lifted by food sales, while Debenhams beats forecasts | | No data |
| Jan 9, 12 | FTSE falters again, as Glaxo reveals mixed drug trial results and AstraZeneca sends out wrong data | | No data |
| Jan 9, 12 | GlaxoSmithKline drops on drug trial results, while AstraZeneca gives City wrong data | | No data |